Assessment of Knowledge Regarding Risks and Benefits of the Use of Non-Vitamin K Antagonist Oral Anticoagulants

• Main Authors: Jose Raul Valery (Author), Ahmad Marar (Author), George Pujalte (Author), Cynthia Ward (Author), Yousif M. Abdelmoneim (Author), Patrick J. Fitzgerald (Author), Edson Mwakyanjala (Author), Dana M. Harris (Author), Loren Murray (Author), Michael G. Heckman (Author), Launia J. White (Author), Fernando Stancampiano (Author)
• Format: Book
• Published: SAGE Publishing, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have replaced vitamin K antagonist (VKA) oral anticoagulants as the first-line treatment option for stroke prevention in high-risk patients with atrial fibrillation. With VKA therapy, disease and treatment-related knowledge is associate...